Retinopathy of Prematurity

"Retinopathy of Prematurity" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

A bilateral retinopathy occurring in premature infants treated with excessively high concentrations of oxygen, characterized by vascular dilatation, proliferation, and tortuosity, edema, and retinal detachment, with ultimate conversion of the retina into a fibrous mass that can be seen as a dense retrolental membrane. Usually growth of the eye is arrested and may result in microophthalmia, and blindness may occur. (Dorland, 27th ed)

Descriptor ID	D012178
MeSH Number(s)	C11.768.836 C16.614.521.731
Concept/Terms	Retinopathy of Prematurity Retinopathy of Prematurity Prematurity Retinopathies Prematurity Retinopathy Retrolental Fibroplasia Fibroplasia, Retrolental Fibroplasias, Retrolental Retrolental Fibroplasias

Below are MeSH descriptors whose meaning is more general than "Retinopathy of Prematurity".

Diseases [C]
Eye Diseases [C11]
Retinal Diseases [C11.768]
Retinopathy of Prematurity [C11.768.836]
Congenital, Hereditary, and Neonatal Diseases and Abnormalities [C16]
Infant, Newborn, Diseases [C16.614]
Infant, Premature, Diseases [C16.614.521]
Retinopathy of Prematurity [C16.614.521.731]

Below are MeSH descriptors whose meaning is more specific than "Retinopathy of Prematurity".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Retinopathy of Prematurity" by people in this website by year, and whether "Retinopathy of Prematurity" was a major or minor topic of these publications.

Bar chart showing 25 publications over 12 distinct years, with a maximum of 4 publications in 2010 and 2018 and 2019 and 2020

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
2004	1	0	1
2005	0	1	1
2010	2	2	4
2013	1	1	2
2015	0	1	1
2016	0	1	1
2018	4	0	4
2019	3	1	4
2020	3	1	4
2021	1	0	1
2022	0	1	1
2023	1	0	1

Below are the most recent publications written about "Retinopathy of Prematurity" by people in Profiles.

Holzapfel LF, Rysavy MA, Bell EF. Red Blood Cell Transfusion Thresholds for Anemia of Prematurity. Neoreviews. 2023 06 01; 24(6):e370-e376.

View in: PubMed
Bell EF, Hintz SR, Hansen NI, Bann CM, Wyckoff MH, DeMauro SB, Walsh MC, Vohr BR, Stoll BJ, Carlo WA, Van Meurs KP, Rysavy MA, Patel RM, Merhar SL, S?nchez PJ, Laptook AR, Hibbs AM, Cotten CM, D'Angio CT, Winter S, Fuller J, Das A. Mortality, In-Hospital Morbidity, Care Practices, and 2-Year Outcomes for Extremely Preterm Infants in the US, 2013-2018. JAMA. 2022 01 18; 327(3):248-263.

View in: PubMed
Brumbaugh JE, Bell EF, Hirsch SC, Crenshaw EG, DeMauro SB, Adams-Chapman IS, Lowe JR, Natarajan G, Wyckoff MH, Vohr BR, Colaizy TT, Harmon HM, Watterberg KL, Hintz SR. Relationships between retinopathy of prematurity without ophthalmologic intervention and neurodevelopment and vision at 2 years. Pediatr Res. 2023 11; 94(5):1720-1730.

View in: PubMed
Backes CH, Rivera BK, Pavlek L, Beer LJ, Ball MK, Zettler ET, Smith CV, Bridge JA, Bell EF, Frey HA. Proactive neonatal treatment at 22 weeks of gestation: a systematic review and meta-analysis. Am J Obstet Gynecol. 2021 02; 224(2):158-174.

View in: PubMed
V?zquez-Otero I, Medina-Cintr?n N, Arroyo-?vila M, Gonz?lez-Sep?lveda L, Vil? LM. Clinical impact of hydroxychloroquine dose adjustment according to the American Academy of Ophthalmology guidelines in systemic lupus erythematosus. Lupus Sci Med. 2020 05; 7(1).

View in: PubMed
Sun M, Wadehra M, Casero D, Lin MC, Aguirre B, Parikh S, Matynia A, Gordon L, Chu A. Epithelial Membrane Protein 2 (EMP2) Promotes VEGF-Induced Pathological Neovascularization in Murine Oxygen-Induced Retinopathy. Invest Ophthalmol Vis Sci. 2020 02 07; 61(2):3.

View in: PubMed
Binenbaum G, Tomlinson LA, de Alba Campomanes AG, Bell EF, Donohue P, Morrison D, Quinn GE, Repka MX, Rogers D, Yang MB, Yu Y, Ying GS. Validation of the Postnatal Growth and Retinopathy of Prematurity Screening Criteria. JAMA Ophthalmol. 2020 01 01; 138(1):31-37.

View in: PubMed
Watkins PL, Dagle JM, Bell EF, Colaizy TT. Outcomes at 18 to 22?Months of Corrected Age for Infants Born at 22 to 25?Weeks of Gestation in a Center Practicing Active Management. J Pediatr. 2020 02; 217:52-58.e1.

View in: PubMed
Natarajan G, Shankaran S, Nolen TL, Sridhar A, Kennedy KA, Hintz SR, Phelps DL, DeMauro SB, Carlo WA, Gantz MG, Das A, Greenberg RG, Younge NE, Bliss JM, Seabrook R, S?nchez PJ, Wyckoff MH, Bell EF, Vohr BR, Higgins RD. Neurodevelopmental Outcomes of Preterm Infants With Retinopathy of Prematurity by Treatment. Pediatrics. 2019 08; 144(2).

View in: PubMed
Ying GS, Bell EF, Donohue P, Tomlinson LA, Binenbaum G. Perinatal Risk Factors for the Retinopathy of Prematurity in Postnatal Growth and Rop Study. Ophthalmic Epidemiol. 2019 08; 26(4):270-278.

View in: PubMed

People

Explore

Similar Concepts

Top Journals